Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2 clinical trials
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

: Endocrine carcinoma of pancreas and digestive tract.) (closed to accrual) Neuroendocrine carcinoma including carcinoid of the lung (closed to accrual 12/19/2017) Pheochromocytoma

adrenal pheochromocytoma
germ cell tumor
mucinous adenocarcinoma
hydrocortisone
desmoid tumor
  • 6048 views
  • 24 Sep, 2021
  • 818 locations
Study of Combination Therapy With the MEK Inhibitor Cobimetinib Immune Checkpoint Blockade Atezolizumab and the AUTOphagy Inhibitor Hydroxychloroquine in KRAS-mutated Advanced Malignancies

This research study is for patients with an advanced cancer that carries a mutation in a gene called KRAS. Genes are parts of our DNA which carry instructions for a cell (the smallest component of an body part). In many cancers, the KRAS gene contains errors (mutations) which allows the …

absolute neutrophil count
capecitabine
cancer
monoclonal antibodies
KRAS
  • 0 views
  • 25 Jan, 2021